151 related articles for article (PubMed ID: 16425312)
21. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
Vestermark LW; Jacobsen A; Qvortrup C; Hansen F; Bisgaard C; Baatrup G; Rasmussen P; Pfeiffer P
Acta Oncol; 2008; 47(3):428-33. PubMed ID: 18348002
[TBL] [Abstract][Full Text] [Related]
22. Population-based study of local surgery for rectal cancer.
Folkesson J; Johansson R; Påhlman L; Gunnarsson U
Br J Surg; 2007 Nov; 94(11):1421-6. PubMed ID: 17661311
[TBL] [Abstract][Full Text] [Related]
23. Locally recurrent rectal cancer in Norway.
Hansen MH; Balteskard L; Dørum LM; Eriksen MT; Vonen B;
Br J Surg; 2009 Oct; 96(10):1176-82. PubMed ID: 19787766
[TBL] [Abstract][Full Text] [Related]
24. Sacral resection for recurrent rectal cancer: analysis of morbidity and treatment results.
Melton GB; Paty PB; Boland PJ; Healey JH; Savatta SG; Casas-Ganem JE; Guillem JG; Weiser MR; Cohen AM; Minsky BD; Wong WD; Temple LK
Dis Colon Rectum; 2006 Aug; 49(8):1099-107. PubMed ID: 16779712
[TBL] [Abstract][Full Text] [Related]
25. Pre- and postoperative adjuvant therapy for locally advanced rectal cancer.
McGartland LP; Mulcahy MF; Benson AB
Clin Adv Hematol Oncol; 2004 Dec; 2(12):806-14. PubMed ID: 16166957
[TBL] [Abstract][Full Text] [Related]
26. Outcomes of resection of stage IV rectal cancer with mesorectal excision.
Law WL; Chu KW
J Surg Oncol; 2006 Jun; 93(7):523-8. PubMed ID: 16705728
[TBL] [Abstract][Full Text] [Related]
27. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E
J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330
[TBL] [Abstract][Full Text] [Related]
28. Results of an aggressive approach to resection of locally recurrent rectal cancer.
Wells BJ; Stotland P; Ko MA; Al-Sukhni W; Wunder J; Ferguson P; Lipa J; Last L; Smith AJ; Swallow CJ
Ann Surg Oncol; 2007 Feb; 14(2):390-5. PubMed ID: 17063304
[TBL] [Abstract][Full Text] [Related]
29. Total pelvic exenteration: results from a multispecialty team approach to complex cancer surgery.
Ho YH; Cheng C; Tay SK
Int Surg; 2001; 86(2):107-11. PubMed ID: 11918234
[TBL] [Abstract][Full Text] [Related]
30. Laparoscopic pelvic autonomic nerve-preserving surgery for patients with lower rectal cancer after chemoradiation therapy.
Liang JT; Lai HS; Lee PH
Ann Surg Oncol; 2007 Apr; 14(4):1285-7. PubMed ID: 17235719
[TBL] [Abstract][Full Text] [Related]
31. Multivisceral resection for primary locally advanced rectal carcinoma.
Harris DA; Davies M; Lucas MG; Drew P; Carr ND; Beynon J;
Br J Surg; 2011 Apr; 98(4):582-8. PubMed ID: 21656723
[TBL] [Abstract][Full Text] [Related]
32. Impact of functional results on quality of life after rectal cancer surgery.
Vironen JH; Kairaluoma M; Aalto AM; Kellokumpu IH
Dis Colon Rectum; 2006 May; 49(5):568-78. PubMed ID: 16583289
[TBL] [Abstract][Full Text] [Related]
33. Quality of life after potentially curative treatment for locally advanced rectal cancer.
Palmer G; Martling A; Lagergren P; Cedermark B; Holm T
Ann Surg Oncol; 2008 Nov; 15(11):3109-17. PubMed ID: 18716841
[TBL] [Abstract][Full Text] [Related]
34. Abdominal sacral resection for posterior pelvic recurrence of rectal carcinoma: analyses of prognostic factors and recurrence patterns.
Akasu T; Yamaguchi T; Fujimoto Y; Ishiguro S; Yamamoto S; Fujita S; Moriya Y
Ann Surg Oncol; 2007 Jan; 14(1):74-83. PubMed ID: 17061173
[TBL] [Abstract][Full Text] [Related]
35. Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers.
Fleisch MC; Pantke P; Beckmann MW; Schnuerch HG; Ackermann R; Grimm MO; Bender HG; Dall P
J Surg Oncol; 2007 May; 95(6):476-84. PubMed ID: 17192947
[TBL] [Abstract][Full Text] [Related]
36. Is surgery-only the adequate treatment approach for T2N0 rectal cancer?
Petersen S; Hellmich G; von Mildenstein K; Porse G; Ludwig K
J Surg Oncol; 2006 Apr; 93(5):350-4. PubMed ID: 16550556
[TBL] [Abstract][Full Text] [Related]
37. Posterior pelvic exenteration for primary rectal cancer.
Bannura GC; Barrera AE; Cumsille MA; Contreras JP; Melo CL; Soto DC; Mansilla JE
Colorectal Dis; 2006 May; 8(4):309-13. PubMed ID: 16630235
[TBL] [Abstract][Full Text] [Related]
38. Treatments and outcomes of malignant tumors of external auditory canal.
Chang CH; Shu MT; Lee JC; Leu YS; Chen YC; Lee KS
Am J Otolaryngol; 2009; 30(1):44-8. PubMed ID: 19027512
[TBL] [Abstract][Full Text] [Related]
39. Long-term results of intraoperative presacral electron boost radiotherapy (IOERT) in combination with total mesorectal excision (TME) and chemoradiation in patients with locally advanced rectal cancer.
Krempien R; Roeder F; Oertel S; Roebel M; Weitz J; Hensley FW; Timke C; Funk A; Bischof M; Zabel-Du Bois A; Niethammer AG; Eble MJ; Buchler MW; Treiber M; Debus J
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1143-51. PubMed ID: 16979835
[TBL] [Abstract][Full Text] [Related]
40. Surgery for local recurrence of rectal cancer.
Heriot AG; Tekkis PP; Darzi A; Mackay J
Colorectal Dis; 2006 Nov; 8(9):733-47. PubMed ID: 17032318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
